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Abstract
Red/near-infrared irradiation therapy (R/NIR-IT) delivered by laser or light-emitting diode (LED) has improved functional
outcomes in a range of CNS injuries. However, translation of R/NIR-IT to the clinic for treatment of neurotrauma has been
hampered by lack of comparative information regarding the degree of penetration of the delivered irradiation to the injury
site and the optimal treatment parameters for different CNS injuries. We compared the treatment efficacy of R/NIR-IT at
670 nm and 830 nm, provided by narrow-band LED arrays adjusted to produce equal irradiance, in four in vivo rat models of
CNS injury: partial optic nerve transection, light-induced retinal degeneration, traumatic brain injury (TBI) and spinal cord
injury (SCI). The number of photons of 670 nm or 830 nm light reaching the SCI injury site was 6.6% and 11.3% of emitted
light respectively. Treatment of rats with 670 nm R/NIR-IT following partial optic nerve transection significantly increased
the number of visual responses at 7 days after injury (P#0.05); 830 nm R/NIR-IT was partially effective. 670 nm R/NIR-IT also
significantly reduced reactive species and both 670 nm and 830 nm R/NIR-IT reduced hydroxynonenal immunoreactivity
(P#0.05) in this model. Pre-treatment of light-induced retinal degeneration with 670 nm R/NIR-IT significantly reduced the
number of Tunel+ cells and 8-hydroxyguanosine immunoreactivity (P#0.05); outcomes in 830 nm R/NIR-IT treated animals
were not significantly different to controls. Treatment of fluid-percussion TBI with 670 nm or 830 nm R/NIR-IT did not result
in improvements in motor or sensory function or lesion size at 7 days (P.0.05). Similarly, treatment of contusive SCI with
670 nm or 830 nm R/NIR-IT did not result in significant improvements in functional recovery or reduced cyst size at 28 days
(P.0.05). Outcomes from this comparative study indicate that it will be necessary to optimise delivery devices, wavelength,
intensity and duration of R/NIR-IT individually for different CNS injury types.
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Introduction
Oxidative stress occurs when the production of reactive oxygen
(ROS) and nitrogen (RNS) species overwhelms the endogenous
antioxidant reducing enzymes, and is considered a hallmark of
injury to the central nervous system (CNS) [1–6]. The high rate of
oxidative metabolic activity and associated reactive oxygen
metabolites, low antioxidant capacity, and high content of
polyunsaturated fats render CNS neurons and glia particularly
prone to the deleterious effects of oxidative stress. Furthermore,
during secondary degeneration, mitochondrial dysfunction and
oxidative stress occur soon after injury [4,7,8]. As such, the
alleviation of oxidative stress is an important therapeutic strategy
for the treatment of neurotrauma. However, despite encouraging
pre-clinical assessments of numerous antioxidants, there are
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currently no effective antioxidant strategies for attenuation of ROS
production in clinical use following neurotrauma [9].
Irradiation in the red/near infrared spectrum (R/NIR, 630–
1000 nm) has been developed as a therapeutic strategy to treat a
range of injuries and diseases. Improvements following R/NIR-IT
have been reported both in animals and humans in a wide range of
injuries and disease including cardial infarct [10], renal and
hepatic complications during diabetes [11,12], and oral mucositis
[13]. In addition, conditions specific to the nervous system have
shown improved recovery following R/NIR-IT, including retinal
degeneration [14,15], CNS injury and stroke [16–22]. Clinical
trials are currently underway assessing R/NIR-IT for stroke, with
NeuroThera Effectiveness and Safety Trial (NEST)-1 and NEST-
2 already completed with some clinical improvement shown
[23,24]. This has led to the commencement of a third trial (NEST-
3). However, the trial was halted following an interim futility
analysis [25], perhaps due to a failure to employ effective
treatment parameters [17].
While there is substantial controversy regarding the mechanism
of action of R/NIR-IT, one widely supported hypothesis is that it
acts by improving oxidative metabolism and reducing oxidative
stress. The enzyme cytochrome c oxidase, complex IV of the
electron transport chain, is proposed to act as a photoacceptor for
irradiation at R/NIR wavelengths, with peaks in its absorption
spectrum matching known efficacious treatment wavelengths.
Irradiation is thought to lead to improvements in oxidative
metabolism via changes in the oxidation-reduction state of the
enzyme [26,27]. Increases in cytochrome c oxidase activity with
R/NIR-IT are associated with increases in adenosine triphosphate
(ATP) content and oxygen consumption in vitro and in vivo,
indicating increased flux through the electron transport chain [28–
30]. This may lead to lower concentrations of reactive species and
reduced oxidative stress, due to maintenance of the mitochondrial
permeability transition [31].
Other potential mechanisms of action of R/NIR-IT have been
suggested, including effects downstream of cytochrome c oxidase
activation. Photo-activation of the chromophores haemoglobin,
myoglobin, flavins and metal free porphyrins may play a role via
as yet unknown mechanisms [32–34]. Nitric oxide catalysed from
cytochrome c oxidase may lead to downstream vasodilatation
[35,36] and signal transduction, potentially contributing to
functional improvements. R/NIR-IT has also been shown to
modulate gene expression [14], reduce apoptosis [29,37], alter
cytokine release and modulate immune responses [20,38–40];
outcomes perhaps independent of modulation of cytochrome c
oxidase activity. Nevertheless, R/NIR-IT has been shown to
reduce indicators of oxidative stress following CNS injury in vivo
[8,22], and may serve as an effective first line antioxidant as part of
a combinatorial strategy to reduce oxidative stress following
neurotrauma.
R/NIR-IT is usually delivered using either lasers or light-
emitting diodes (LEDs). LEDs are an increasingly accepted source
for R/NIR-IT [41]. It was originally thought that the coherence of
laser light was essential to achieve the therapeutic effects of R/
NIR-IT, resulting in the widespread use of HeNe lasers (which
emit light at a wavelength of 632.8 nm) [41]. More recently,
therapeutic benefits of R/NIR-IT have been observed using non-
coherent light sources such as LEDs [37,42,43], giving credence to
the concept of using cheaper and more convenient LED devices to
administer treatment. However, very few studies have reported the
efficacy of R/NIR-IT delivered by LED for treatment of TBI or
SCI in vivo. Furthermore, few studies have quantitatively
compared the therapeutic effects of different wavelengths of light
[20,29,44–47] and, to our knowledge, none of these compared
different wavelengths of R/NIR-IT, delivered by LED, in more
than one in vivo model of CNS injury. The therapeutic dose can
be defined by the number of photons interacting with the
photoacceptor (chromophore). As the energy of a photon varies
with its wavelength, intensities of irradiation can be adjusted to
ensure delivery of equal numbers of photons to provide an
effective comparison of the efficacy of R/NIR-IT of different
wavelengths [48]. We have conducted a multi-centre study
designed to compare efficacy of equal numbers of photons of
670 nm and 830 nm R/NIR-IT, delivered to the surface of the
skin overlying injury sites using LED arrays, in four models of
CNS injury, each of mild to moderate severity: 1) in a model of
secondary degeneration following partial injury to the optic nerve;
2) in light-induced retinal degeneration; 3) in traumatic brain
injury (TBI) induced by fluid percussion impact; and 4) following a
moderate contusion spinal cord injury (SCI). The R/NIR-IT
treatment parameters were kept constant for the three traumatic
injury models. Because previous experiments had established the
approximate parameters for effective treatment of the retina, a 10-
fold lower dose, delivered prior to light damage, was used in the
retinal degeneration model. Penetrance of R/NIR-IT to the eye is
greater than to the other CNS injury sites [22]. As such, delivery of
the full dose to the retina that was used in the other CNS injury
models would have resulted in unnecessary exposure to excess
irradiation. We have already determined that there is no benefit in
delivering this tenfold greater dose in the retinal degeneration
model (unpublished). Although we delivered equal numbers of
photons of each light source (670 and 830 nm) to the surface of the
body, it is possible that any differences in the spectral transmission
properties of the intervening tissue(s) could affect the relative
irradiance actually received at the injury site. However, given the
difficulties in measuring these transmission properties in vivo,
especially in thick highly-scattering tissues, we attempted to equate
quantal irradiance as far as practicable. We have assessed
treatment outcomes of behavioural function or neuroprotection,
of lesion volume, and of oxidative stress, as appropriate for each
model system, and demonstrated differential effects dependent on
wavelength used and injury type.
Materials and Methods
All procedures involving animals complied with the ‘‘Principles
of Laboratory Animal Care’’ (National Institutes of Health
publication no. 86–23, revised 1985) and were approved by the
relevant institutional Animal Ethics Committee (The University of
Western Australia approvals: RA3/100/673, RA3/100/1247;
Australian National University approval A2011/029; University
of Adelaide approval M-2013-160).
R/NIR-IT delivery, calibration and treatment
The spectral transmittance (300–890 nm) of an excised block of
skin and muscle (plus the skin and muscle separately for
information purposes) lying dorsal to the spinal column of a
Fischer rat cadaver was measured to assess the degree to which
light penetrates to the site of injury in the contusion SCI rat model.
Broadband ‘white’ light from a 175 W xenon lamp (Spectral
Products, CT, USA) was delivered to the dorsal surface of excised
tissue via a 600 mm diameter quartz fibre optic fitted with a quartz
collimating lens. Light transmitted by the tissue was collected via a
cosine-corrector (CC-3-UV, Ocean Optics, Dunedin, FL, USA;
covered with a thin layer of ‘cling-wrap’) connected to a 1000 mm
diameter quartz fibre optic that delivered the light to an Ocean
Optics USB4000 CCD spectroradiometer. Data acquisition was
controlled through SpectraSuite software (Ocean Optics). The
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irradiance of R/NIR-IT received at the spinal cord was calculated
by multiplying the spectral irradiances produced by the 670 and
830 nm devices at a surface of the skin, by the measured spectral
transmittance of the skin and muscle.
R/NIR-IT was delivered to live rats using two different LED
arrays: 670 nm R/NIR-IT from a commercially available device
(VET75, Quantum Devices Inc, Barneveld, WI, USA) or 830 nm
R/NIR-IT from a custom built device. The custom built
adjustable intensity 830 nm LED array was constructed from
infra-red LEDS and had a similar emission cross sectional area to
the Vet75 device (70 cm2). The light output of the custom built
830 nm LED array was adjusted to produce an equal photon
irradiance (5.3361016 photons cm22 s21) to the VET75 670 nm
LED array, at the surface of the skin (3 cm from the LED array).
Because of the difference in photon energy at these two
wavelengths, this equal quantal dose equates to an energy dose
of 28.4 J cm22 for the 670 nm array and 22.6 J cm22 for the
830 nm array. Treatment of all rats with R/NIR-IT delivered by
LED array was conducted using consistent procedures for each
model of CNS injury. Rats were either gently held by hand or
within a clear perspex box such that the LED arrays delivered
irradiation at a distance of 3 cm above the surface of the skin
overlying the injury, or 2.5 cm from the eye for the retinal
degeneration model. Rats were conscious throughout treatment
except for the first treatment after surgery, for which they were still
anaesthetised. For the traumatic injury models, treatment duration
was 30 minutes, delivered once per day, commencing immediately
following surgical injury and continuing until euthanasia; control,
sham-treated rats were similarly handled, but the overlying LED
array was not turned on (referred to as control). For the retinal
degeneration model, treatment duration was 3 minutes (resulting
in lower doses of 3.4 J cm22 for the 670 nm array or 2.7 J cm22
for the 830 nm array at the eye, in this model) and occurred daily,
for the 5 days prior to 24 hours’ exposure to bright light.
Partial optic nerve injury animals and surgery
Adult, female Piebald-Virol-Glaxo (PVG) hooded rats were
procured from the Animal Resources Centre (Murdoch, WA), and
housed under temperature controlled conditions on a 12 hour
light/dark cycle, with access to standard rat chow and water ad
libitum. The partial optic nerve transection procedure was
conducted as described elsewhere [4]. Briefly, PVG rats were
anaesthetized (i.p. injection of 50 mg/kg ketamine hydrochloride
and 10 mg/kg xylazil hydrochloride, Troy Laboratories, NSW,
Australia), the right optic nerve exposed surgically and a diamond
keratotomy knife (Geuder, Germany) used to make a controlled
dorsal incision in each ON, to a depth of 200 mm. Post-operative
analgesia was provided once (subcutaneous injection of 2.8 mg/kg
Carprofen; Norbrook Australia, Pty. Ltd., VIC, Australia). Each
treatment or control group consisted of 12 rats, and the groups
were control, 670 nm or 830 nm R/NIR-IT treated, i.e. a total of
36 rats for this model, all animals experienced partial optic nerve
transection.
Optokinetic nystagmus visual reflex was assessed in all rats 7
days after injury and daily R/NIR-IT using established procedures
[22], by an investigator blinded to animal identity and treatment.
Following behavioural assessments, under anaesthesia as described
above, the injured optic nerves in 6 rats/treatment group were
dissected from the ocular cavity, collected onto a microscope slide
maintained at 220uC over a bed of dry ice, mounted in O.C.T.
(optical cutting temperature compound) (Tissue-Tek, Sakura,
Japan) then snap-frozen in eppendorf tubes in liquid nitrogen.
Rats were then euthanased with Lethabarb (800–1000 mg/kg
i.p, Virbac, Australia Pty. Ltd., NSW, Australia). Immediately
following euthanasia, the remaining 6 rats per treatment group
were transcardially perfused with 0.9% saline followed by 4%
paraformaldehyde (PFA) (0.1 M phosphate buffer; pH 7.2) for
immunohistochemical assessments of optic nerves.
Partial optic nerve injury outcome measures
Fresh-frozen optic nerves were cryosectioned longitudinally at
220uC and free floating tissue sections (20 mm thickness) from
each rat were labelled with 10 mM dihydroethidium (DHE) (Life
Technologies, VIC, Australia) in phosphate buffered saline (PBS)
for 10 minutes, for detection of reactive species. Optic nerves for
immunohistochemical analyses were cryosectioned and processed
according to established procedures [4], using primary antibodies
recognising: manganese superoxide dismutase (MnSOD) (1:500,
Stressgen); heme oxygenase-1 (HO-1) (1:200; Abcam); glutathione
peroxidase 1 (GPx1) (1:250; Abcam); 3-nitrotyrosine (3NT) (1:500;
Abcam); 4-hydroxynonenal (HNE) (1:200; Jomar Bioscience); 8-
hydroxyguanosine (8OHDG) (1:500; Abcam); NG2 (1:250,
Invitrogen) and olig2 (1:500, Abcam) to recognise oligodendrocyte
precursor cells as well as Hoechst nuclear stain (1:1000;
Invitrogen, VIC, Australia). Secondary antibodies were species-
specific AlexaFluor 555- and 488-conjugated antibodies (1:500;
Invitrogen, VIC, Australia).
Reactive species and immunohistochemical labelling were
visualized in a single section of ventral optic nerve directly below
the primary injury site for each animal, and photographed using a
Leitz Diaplan fluorescence microscope (Leica, Germany). All
images for each outcome measure were captured at constant
exposures and in a single session. Image analysis was conducted on
a single image using Image J/Fiji analysis software, setting
constant arbitrary threshold intensities for all images in an analysis
and semi-quantifying mean intensities and areas above that
threshold. Data shown are either mean areas or intensities above
threshold, with choice of analysis dependent on the pattern of
staining and the most pronounced increases observed with injury
compared to normal optic nerve (unpublished data).
Retinal degeneration animals and light damage
Albino Sprague-Dawley rats were born and reared in dim cyclic
light conditions (12 hr:12 hr, light:dark) with an ambient light
level of approximately 5 lux. Between post-natal days (P) 90–120,
and following 5 days of R/NIR-IT pre-treatment, photochemical
damage to the retina (light damage, LD) was induced in some
groups of rats by 24 hours’ exposure to a cold-white fluorescent
light source positioned above the cages (18 W, Cool White; TFC),
at an intensity of approximately 1000 lux at the cage floor. The six
treatment or control groups consisted of 6 rats (n = 6), - control,
670 nm or 830 nm R/NIR-IT treated, LD, 670 nm+LD and
830 nm+LD - a total of 36 rats. At the end of the LD period, rats
were euthanized with an overdose of barbiturate (60 mg/kg
bodyweight i.p., Valabarb; Virbac, Milperra, Australia).
Retinal degeneration outcome measures
The eyes from the animals was marked at the superior surface
for orientation, enucleated and then processed for cryosectioning
by immersion fixation in 4% PFA in 0.1 M PBS (pH 7.3) for 3 h
at room temperature. The fixed eyes were then washed in PBS
(365 minutes) and placed in 30% sucrose overnight. Eyes were
oriented and embedded in O.C.T. compound, snap frozen in dry
ice cooled acetone and cryosectioned at 16 mm. The sections were
mounted on superfrost-plus glass slides and dried overnight at
37uC. Sections were stained for histological examined using either
immunohistochemistry or TUNEL.
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TUNEL staining was used to quantify photoreceptor apoptosis/
death following LD in frozen sections using our published method
[49]. Counts of TUNEL positive cells in the outer nuclear layer
(ONL) were carried out along the retinal sections cut in the para-
sagittal plane (superoinferior), including the optic disc. The final
count from each animal was then averaged at comparable
locations in two non-sequential sections. Sections adjacent, or
close, to those used for TUNEL analysis were used for
immunohistochemistry. Sections were rehydrated in graded
ethanols and then placed in 10% normal goat serum (Sigma) for
1 h to block non-specific binding. Primary antibodies were GFAP
(1:700 Dako); and 8OHDG (1:500; Abcam) incubated overnight at
4uC. Secondary antibodies were anti-mouse IgG-alexa 594 or anti-
rabbit IgG-alexa 488 (1:1000, Life Technologies) incubated
overnight at 4uC. Sections were washed in 0.1 M PBS and
coverslipped in a ProLong Gold Antifade (Life Technologies).
Primary antibodies were omitted for controls assessing non-specific
binding of the secondary antibody. Images were visualised and
captured using a LSM5 Confocal microscope (Zeiss), Pascal (Zeiss,
v4.0) and prepared using Photoshop CS5 (Adobe). No manipu-
lation to the intensity or gain was performed using either software.
TBI animals and surgery
A total of 21 adult male Sprague-Dawley rats (weighing between
300–330 grams) were randomly assigned into 4 groups: sham
uninjured animals (n = 5), injured untreated controls (n = 6),
670 nm R/NIR-IT treated (n= 5), 830 nm R/NIR-IT treated
(n = 5). To administer TBI (n = 16) we used the lateral fluid
percussion model (LFP), which has been co-developed by our
laboratory in collaboration with others [50] This focal model of
TBI produces extensive oxidative stress, inflammation, ion
changes, mitochondrial damage and energy crisis, along with
both motor and cognitive deficits [51]. Briefly, rats were obtained
one to two weeks prior to injury and group housed with
unrestricted access to food and water. On the day of trauma,
rats were initially anaesthetised via nose cone induction by
inhalation of 3–4% isoflurane in 1.5 L/min O2, subsequently
intubated and then mechanically ventilated to a surgical level by
inhalation of 1–2% isoflurane in 1.5 L/min O2.
Under anaesthesia, a midline incision was made on the skin
overlaying the skull and the bone exposed. Lignocaine (local
anaesthetic) was injected prior to incision. After exposing the skull,
a 4 mm craniotomy centered over the parietal cortex between the
midline and the temporal ridge was performed using a trephine
drill. Care was taken not to damage the dura which was left intact
at the opening. A female luer loc was then cemented over the
craniotomy using polyacrylamide adhesive. The injury device was
connected to the female luer loc using a male luer loc fitting. The
device then induced injury by generating a 25 msec saline pressure
pulse which was transmitted to the brain. This pressure pulse
results in a transient deformation of brain tissue at the site of the
craniotomy. The amplitude of the pressure pulse was measured
using a pressure transducer. In our experience, a 2.5 atmosphere
pressure pulse results in moderate injury. Throughout this
procedure the rats remained anaesthetized. After confirming that
the condition of the rat was stable, the luer loc fitting was removed,
the craniotomy was sutured, the skin sutured and the animals
removed from anaesthesia to permit recovery. Throughout all
procedures, temperature of rats was maintained at 37uC using a
heating pad. Rats usually woke within 15 minutes of injury and
were exhibiting normal exploratory behaviour within 60 minutes.
TBI outcome measures
Rats motor abilities were assessed by their ability to remain on a
rotarod, according to established procedures [52]. Rats were
trained on the rotarod for 5 days prior to injury unless they
recorded the maximum time of 120 seconds for 2 consecutive
days, in which case they were deemed trained. The final day of the
training day was used as the pre-injury score. Rats were assessed at
the same time each day for the 7 R/NIR-IT treatment days
following injury. The Bilateral Asymmetry Test was used to assess
sensory function. Forepaw latency was assessed according to
established procedures [53], on both the ipsilateral and contralat-
eral forepaws prior to induction of injury. Latency of both
forepaws was then assessed on days 1, 3 and 7 post-injury. Due to
the individual variability between animals, each rat’s contralateral
forepaw latency (forepaw which is affected) was compared to their
ipsilateral forepaw latency to give a percentage of latency score.
Following perfusion fixation at 7 days after injury with 10%
formalin, a 10 mm section of whole brain (Bregma; 1.0 mm to 2
9.0 mm AP) (Paxinos and Watson Rat brain stereotaxic atlas) was
processed and embedded in paraffin. Serial sections were taken at
every 250 um interval for the entire described brain region.
Sections were stained with Haematoxylin and Eosin stain, scanned
using the Hamamatsu Nanozoomer and viewed with the
associated software. The area of the lesion was circumscribed
using this software, with the area recorded for each section. The
following equation was then used to determine lesion volume
(mm3): =g (lesion volume of each section) * 0.25 (250 um): this
method has been used routinely within our laboratory, modified
from Corrigan et al., (2012) [54].
SCI animals and surgery
Adult female Fischer rats (F344, 160–190 g) were bred at the
Animal Resources Center (Animal Research Center, Murdoch,
W.A.), housed under a standard 12 h light/dark cycle, fed wet and
dry rat chow and water ad libitum. Each treatment group
consisted of 7 or 8 rats, groups were control, 670 nm or 830 nm
R/NIR-IT treated, total n = 22 for this model, all rats received the
SCI. Moderate contusion SCI was performed as described in [55]
and in brief as follows; rats were anaesthetised by i.p. injection of
xylazine in combination with ketamine (50 mg/kg ketamine
hydrochloride and 10 mg/kg xylazil hydrochloride, Troy Labo-
ratories, NSW, Australia). Amacin ophthalmic eye ointment
(Provet, Queensland, Australia) was applied after the rats were
placed under anaesthetic. A longitudinal incision and partial
laminectomy were performed at vertebral level T9–T10 to expose
the underlying thoracic spinal cord without disrupting the dura.
Rats were positioned on a surgical plate for spinal cord impact
using flexible armatures and Adson forceps (spinal cord stabilizing
forceps). All rats received a moderate contusion injury (200KDyne)
using an Infinite Horizon impactor device on the dorsal surface of
the exposed spinal cord. Rats were maintained in a temperature
and humidity controlled chamber until recovery from anaesthetic.
Rehydrating saline (2 mL) in conjunction with Buprenorphine
Hydrochloride (Provet) (Temgesic, 0.01 ml/100 g body weight,
300 U/ml) and intramuscular injection of Benicillin (Provet)
(0.02 mL/100 g body weight, 300 U/mL) was administered
immediately after surgery and every 12 h thereafter to hydrate
and act as an analgesic respectively. Bladders were manually
expressed every 12 h until function was recovered and total
volumes of given saline were adjusted for rat bladder size.
Frequency of saline - Temgesic injections was reduced to every
24 h when animals were able to drink unassisted, and generally
ceased around day 7–10 after SCI. 50 uL of Benicillin (Provet,
0.02 ml/100 g body weight, 300 U/mL, (150 mg/ml procaine
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penicillin, 150 mg/ml benzathine penicillin, 20 mg/ml procaine
hydrochloride; Troy Laboratories Pty. Ltd., Glendenning, NSW,
Australia)) was administered intramuscularly immediately after
surgery and at 2, 4 and 6 days to prevent wound and bladder
infections.
SCI outcome measures
Functional assessments were performed on days 1, 2, 3, 7, 14,
21 and 28 following surgery and daily R/NIR-IT, and consisted of
open field locomotion assessment, quantitative gait analysis
(Ratwalk) and ladder walking. The Basso, Beattie, Bresnahan
(BBB) locomotor rating scores were used to assess the range and
type of open field spontaneous forward locomotion [56]. Rats were
recorded in an open field for 4–5 minutes on days 7, 14, 21 and
28-post injury. Video recordings were made on the left, right and
posterior views of the animal. Scoring was by 3 independent
assessors blinded to animal treatments: assessors had to score
animals within 1 point of each other or animals were re-assessed.
Quantitative gait analysis using Ratwalk was performed at days
14, 21 and 28-post injury under red light, according to established
procedures [57] and assessed using Ratwalk software. The stride
length was obtained by measuring the distance (in pixels) between
successive placements of an individual paw. Ladder walking was
also assessed at days 14, 21 and 28 days post-injury. All rats were
recorded walking the length of the ladder walk apparatus 3 times
per session. Analysis was performed using video recordings,
analysed frame-by-frame by 3 independent scorers. The foot
faults for both the left and right limbs were recorded over the total
distance travelled [58].
At day 28-post injury, animals were euthanized by lethal
injection of sodium pentobarbitone (Provet; 50 mg/100 g) and
perfused with approximately 200 mL of 1% (v/v) Heparin (Prover)
in PBS, followed by approximately 250 mL of 4% (w/v)
paraformaldehyde pH 7.2 (Sigma) in PBS. Spinal cords were
dissected and cryosectioned longitudinally (40 mm). Sections were
stained with toluidine blue for assessment of cyst size and for
immunohistochemical analysis according to established proce-
dures [55] (n = 4/group), using antibodies to: glial fibrillary acidic
protein (GFAP) (1:400, Dakopatts); b-III tubulin (1:400, Covance);
neuronal doublecortin (DcX) (1:400, Novex); GAP43 (1:400,
Invitrogen) and activated macrophage ED1 (CD68) (1:400,
Serotec). Secondary antibodies were species specific AlexaFluor
555- and 488-conjugated antibodies (1:500; Invitrogen).
Toluidine blue sections were scanned at high power magnifi-
cation (40x) using a ScanScope digital slide scanner with Aperio
Software. Analysis of the cyst area was carried out using the
software Image-Pro Plus (Image-Pro version 3.0 for Windows,
Media Cybemetics Image-Pro, Rockville MD) where the total area
of cystic structures within 65 mm (rostral-caudal axis) from the
epicenter of the lesion was calculated as a percentage of total
tissue. Immunohistochemical labelling was visualized in sections
taken within the central part of the lesion (n= 4) in each treatment
group (repeated 2x), and photographed using a Nikon Eclipse
E800 microscope. All images for each outcome measure were
captured at constant exposures and in a single session.
Statistical analyses
All data were expressed as mean 6 SEM: statistical analyses
were conducted using SPSS statistical software (IBM) or PRISM
(GraphPad Software). Data were analyzed using two-tailed
Student’s t test, one- or two-way ANOVA and Bonferroni Dunn
or Dunnett’s post-hoc tests as appropriate (F values, degrees of
freedom (dF) and post-hoc test p values given). In the case of the
open field locomotion test, the Kruskal Wallis post-hoc test for
non-parametric data was used. Ladder walk analysis was
performed using two-way ANOVAs comparing identical treat-
ment groups over days 14, 21 and 28, and experimental conditions
at each time point. Probabilities #0.05 were considered signifi-
cant.
Results
Penetrance of light including R/NIR to a CNS injury site
The effect of wavelength of light on penetrance of R/NIR light
through skin and/or muscle was assessed by measuring the
spectral transmittance (300 nm to 890 nm) of the tissue overlying
the spinal cord in a Fischer rat cadaver, allowing calculation of the
irradiation doses received at the injury site in the SCI model.
Transmittance was higher through skin than muscle, and was
greatest between 750–890 nm, with a minor secondary peak at
around 500 nm (Fig. 1A). Unlike lasers, LEDS are not mono-
chromatic and instead are narrowband light sources that emit
significant amounts of light either side of the specified emission
peak (Fig. 1A, B). Thus, measured irradiances produced by the
LED devices are integrated over the wavelength range 400–
890 nm. The total irradiance of R/NIR-IT received at the surface
of the skin, 3 cm from the emission surface of the 670 nm device,
was 5.361016 photons cm22 s21 (peak irradiance at 670 nm was
approximately 261015 photons cm22 s21) and this was calculated
to drop to 3.561015 photons cm22 s21 (6.6%) at the SCI injury
site, below the overlying skin and muscle (Fig. 1B). Similarly, the
total irradiance of R/NIR-IT received at the surface of the skin,
3 cm from the surface of the 830 nm device, was 5.361016
photons cm22 s21 (peak irradiance at 830 nm was approximately
1.261015 photons cm22 s21) and this dropped to 6.061015
photons cm22 s21 (11.3%) at the SCI injury site (Fig. 1C).
Effects of R/NIR-IT following partial optic nerve injury
Partial dorsal optic nerve transection leaves the remaining
ventral optic nerve vulnerable to secondary degeneration, and
provides a model to assess efficacy of therapeutic strategies to
prevent spreading damage following injury to the CNS [59].
Analysis of functional behaviour following partial optic nerve
transection and R/NIR-IT was assessed using the optokinetic
nystagmus visual reflex at 7 days after injury. R/NIR-IT delivered
at 670 nm led to a significantly increased number of smooth
pursuits and fast reflexes compared to numbers of responses by
injured, control animals (F = 12.8 and 3.9 respectively, dF= 2, P#
0.05), indicating improved visual function and confirming previous
findings [22]. R/NIR-IT at 830 nm resulted in significantly more
smooth pursuits compared to control (F = 12.8, dF= 2, P#0.05),
but there was no significant improvement in the number of fast
resets (F = 3.9, dF= 2, P.0.05, Fig. 2A). There were no significant
differences between either numbers of smooth pursuits or fast reset
responses by rats treated with 670 nm R/NIR-IT, compared to
rats treated with 830 nm R/NIR-IT (P.0.05) (Fig. 2A).
DHE fluoresces upon oxidation by a range of reactive species
and was used to semi-quantify increases in ROS/RNS, in fresh
frozen tissue sections. Note that data shown here and throughout
are either mean areas or mean intensities above threshold, with
choice of analysis dependent on the pattern of staining and the
most consistent or pronounced increases observed with injury
compared to normal optic nerve (unpublished data). In ventral
optic nerve vulnerable to secondary degeneration, there was a
small but significant decrease in the mean fluorescence intensity of
DHE, when animals were treated with 670 nm R/NIR-IT
(F= 5.3, dF= 2, P#0.05) (Fig. 2B), indicating that 670 nm R/
NIR-IT reduced ROS/RNS in CNS tissue vulnerable to
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spreading damage at 7 days. There was no effect of R/NIR-IT
delivered at 830 nm on DHE fluorescence at this time (F = 5.3,
dF= 2, P.0.05) (Fig. 2B).
The intensities of immunoreactivity of the antioxidant enzymes
MnSOD, HO-1 and GPx1 were quantified in ventral optic nerve
vulnerable to secondary degeneration at 7 days following injury.
We observed no significant change in immunoreactivities when
animals were treated with either 670 nm or 830 nm R/NIR-IT,
compared to control at this time (F= 4.6, 4.5 and 1.7 respectively,
dF= 2, P.0.05) (Figs. 2C–E), in contrast to our reported
reductions in MnSOD following 670 nm R/NIR-IT at 1 day
after injury[22]. MnSOD and HO-1 immunoreactivities in
animals treated with 830 nm R/NIR-IT were significantly lower
than in rats treated with 670 nm R/NIR-IT (F= 4.6 and 4.5
respectively, dF= 2, P#0.05) (Figs. 2C–E). Similarly, there was no
change in the immunoreactivity of the indicator of protein
nitration 3NT or the indicator of oxidized DNA 8OHDG in
ventral optic nerve, when rats were treated with either 670 nm or
830 nm R/NIR-IT, compared to control at 7 days (F= 5.0 and
4.6 respectively, dF= 2, P.0.05) (Figs. 2F, G). However, immu-
noreactivities of both 3NT and 8OHDG in rats treated with
830 nm R/NIR-IT were significantly lower than in rats treated
with 670 nm R/NIR-IT (F= 5.0 and 4.6 respectively, dF= 2, P#
0.05) (Figs. 2F, G). Importantly, the immunoreactivity of the
indicator of lipid oxidation HNE, was significantly reduced relative
to control, when animals were treated with either 670 nm or
830 nm R/NIR-IT (F= 15.0, dF= 2, P#0.05) (Fig. 2H), indicat-
ing reduced oxidative stress. There was no significant difference in
HNE immunoreactivity between the two wavelengths of R/NIR-
IT at this time (F= 15.0, dF= 2, P.0.05) (Fig. 2H).
Effects of R/NIR-IT on light-induced retinal degeneration
Light damage induces cell death, indicated by large numbers of
TUNEL positive (+) cells in rat retina from as early as 6 hours
after injury, particularly in the photoreceptor layers, as described
previously [60,61]. We detected no effect of pre-treatment with
830 nm R/NIR-IT on numbers of TUNEL+ cells relative to
controls (F = 1.417, dF= 5, P.0.05) (Fig 3A). In contrast, we
observed a significant decrease in the total number of TUNEL+
photoreceptors in the outer nuclear layer of LD retinae pre-treated
with 670 nm R/NIR-IT compared with controls, confirming
previous findings (F = 1.678, dF=5, P#0.05) [62,63]. The lower
numbers of TUNEL+ cells in retinas treated with 670 nm R/NIR-
IT were significant in samples taken from both superior retina and
inferior retina (F = 3.423, dF=2, P#0.05) (Fig. 3B). Immunore-
activity for 8OHDG, indicative of oxidised DNA and therefore
oxidative stress, was significantly reduced in LD retinae treated
with 670 nm R/NIR-IT (F= 1.632, dF= 4, P#0.05), but not
those treated with 830 nm R/NIR-IT (F= 3.267, dF= 4, P.0.05)
(Fig. 3C). While there was a trend towards reduced GFAP
immunoreactivity following treatment of light damaged retinae
with 670 nm R/NIR-IT, this was not significant (F= 1.867 dF= 4,
P.0.05) (Figs. 3C, D).
Effects of R/NIR-IT following TBI
The fluid percussion model was used to assess efficacy of
670 nm and 830 nm R/NIR-IT at improving motor and sensory
outcomes as well as decreasing lesion volume following TBI.
Motor ability of injured rats was assessed daily by quantifying the
length of time rats could remain on a rotarod. As expected [64],
there was a substantial decrease in rotarod score relative to pre-
injury in control animals (significant for the first 3 days following
injury, P#0.05), which gradually improved during the 7 days
following injury (Fig. 4A). R/NIR-IT at 670 nm or 830 nm did
not affect motor outcomes during the 7 days following TBI,
relative to control (F = 0.5, dF= 2, P.0.05) (Fig. 4A). Sensory
ability was assessed using the bilateral asymmetry test as has been
described [53], at 1, 3 and 7 days following injury, compared to
pre-injury performance. However, somewhat unexpectedly, there
was no significant difference in contralateral vs ipsilateral latency
in control (sham treated) rats when comparing pre- and post-injury
outcomes for the first 7 days after injury (F= 0.4, dF= 2, P.0.05)
(Fig 4B). Sensory abilities in rats treated with R/NIR-IT at
670 nm or 830 nm were not different to control rats or pre-injury
levels (F = 0.4, dF= 2, P.0.05) (Fig. 4B). Lesion volume at 7 days
following TBI was also not altered by R/NIR-IT at either 670 nm
or 830 nm (F=0.1, dF= 2, P.0.05) (Fig. 4C).
Effects of R/NIR-IT following SCI
Analysis of functional recovery following moderate contusion
SCI and R/NIR-IT was conducted, assessing open field locomo-
tion (BBB), quantitative gait analysis (Ratwalk) and ladder walking.
Rats were scored for their performance on the BBB test at 7, 14,
21 and 28 days following SCI [56]. All animals exhibited a steep
recovery from day 0 to 7 and were able to weight support by day
14 (BBB score of 9). At day 21, the scores began to plateau and the
average score across all groups was 10. At day 28 the average score
for all groups was 11 - characterised by frequent to consistent
weight-supported plantar steps and no forelimb - hindlimb
coordination. There were no significant differences in BBB scores
of rats treated with either wavelength of R/NIR-IT compared to
control rats (Fig. 5A, F= 0.5, dF= 2, P.0.05). Although no
significance was recorded, it is important to note that even though
the applied Kruskal-Wallis test is an analysis of variance for non-
parametric data, the BBB scale is neither linear nor exponential.
Higher BBB values represent a score comprised of increasing
numbers of variables that are often unrelated to previous (lower)
scores. Careful interpretation should always be exercised when
equating biological significance with statistical significance in such
cases [65].
The gait of rats in the treatment groups was analysed using
Ratwalk computer software at days 14, 21 and 28 following SCI
and R/NIR-IT, and stride lengths were quantified. Data
generated from animals pre-injury were used to illustrate ‘normal’
locomotor patterns (baseline) and as a reference point for
comparison to R/NIR-IT treated rats following SCI. Data
generated from left and right limbs of the fore-and hindquarters
were compared and no significant differences were found (P.
0.05). Therefore, data generated from left and right forelimbs and
left and right hindlimbs were averaged and referred to as forelimbs
and hindlimbs respectively. The stride length of forelimbs
following SCI was significantly reduced in all treatment groups
and time-points following injury, compared to scores generated
from pre-injury animals (Fig. 5B, 28 day data shown, F= 15.4,
dF= 3, P#0.05). This indicated that there was some compensatory
change in forelimb movement following SCI, most likely as
Figure 1. Penetrance of light through rat skin and muscle and irradiance delivered by the 670 nm and 830 nm R/NIR-IT LED arrays.
(A) Spectral transmittance of light from 300 nm to 890 nm through skin (red), muscle (green), and skin plus muscle combined (blue), taken from the
area overlying the SCI injury site in a Fischer rat cadaver (n = 1). Spectral irradiance (300–890 nm) received at the surface of the skin from the 670 nm
(B) or 830 nm (C) LED arrays at a distance of 3 cm (blue lines) and calculated numbers of photons reaching the SCI injury site (red line).
doi:10.1371/journal.pone.0104565.g001
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hindlimb function is impaired. The animals use their forelimbs to
propel their body forward, a movement which would not
otherwise be possible if the stride length of the forelimb remained
at its original pre-injury distance. However, there were no
significant differences in forelimb stride length of rats treated with
either wavelength of R/NIR-IT compared to control sham-treated
rats (Fig. 5B, F= 15.4, dF= 3, P.0.05). The stride length of the
hindlimbs did not change with SCI (Fig. 5B, F= 1.6, dF= 3, P.
0.05).
There were significantly more hindlimb missteps following SCI
at each time point assessed, for both R/NIR-IT treated and
control groups (F = 3.4, dF= 6, Fig. 5C, P#0.05), compared to
pre-injury performance. The total number of missteps at 21 and
28 days after injury, for the control and 670 nm R/NIR-IT
Figure 3. Number of Tunel+ cells, 8OHDG and GFAP immunoreactivity following pre-treatment with 670 nm or 830 nm R/NIR-IT or
sham treatment and light induced retinal degeneration, compared to uninjured animals. Mean 6 SEM total number of Tunel+ cells/
retinal section (A) and number of Tunel+ cells in superior and inferior retina (B) were quantified. Mean6 SEM 8OHDG and GFAP immunoreactivities in
retinal sections were semi-quantified (C): *indicates significantly different from injured control (P#0.05), n = 6/group. Representative images of
8OHDG (green) and GFAP (red) immunofluorescence from control and R/NIR-IT treated animals are shown (D) (scale = 200 mm).
doi:10.1371/journal.pone.0104565.g003
Figure 2. Visual behaviour, reactive species, antioxidant enzymes and indicators of oxidative damage 7 days following partial optic
nerve transection and treatment with 670 nm or 830 nm R/NIR-IT compared to sham treated control. Number of responses in the
optokinetic nystagmus visual reflex task (A) were quantified as smooth pursuits (black) or fast resets (grey), n = 12/group. Mean 6 SEM DHE
fluorescence (B), MnSOD (C), HO-1 (D), GPx1 (E), 3NT (F), 8OHDG (G) or HNE (H) immunoreactivity in ventral ON vulnerable to secondary degeneration
were semi-quantified: *indicates significant differences (P#0.05), n = 6/group.
doi:10.1371/journal.pone.0104565.g002
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Figure 4. Motor and sensory function as well as lesion size following fluid percussion TBI and treatment with 670 nm or 830 nm R/
NIR-IT compared to sham treated control.Mean6 SEM length of time animals remained on a rotarod (A), and contralateral vs ipsilateral latency
(B) were quantified as measures of motor and sensory function respectively over the 7 days following TBI. Lesion volumes were also quantified at 7
days following injury (C): there were no significant differences relative to control at each time point (P.0.05), n = 5 or 6/group.
doi:10.1371/journal.pone.0104565.g004
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groups, was significantly lower than the number of missteps at 14
days (F= 3.4, dF= 6, Fig. 5C, P#0.05), whereas treatment with
830 nm R/NIR-IT only resulted in significant decreases in the
total number of missteps at 28 days, compared to 14 days (F = 3.4,
dF= 6, Fig. 5C, P#0.05). However, there were no significant
differences between R/NIR-IT treatment and control groups at
any of the time points assessed (F= 3.4, dF= 6, P.0.05).
Cyst size and morphological parameters, including the amount
of degenerative tissue immediately surrounding the cyst, were
assessed in toluidine blue stained sections and using immunohis-
tochemical assessments of GFAP, b-III tubulin, DcX and GAP43
immunoreactivity at 28 days following SCI. The borders of larger
cysts stained with toluidine blue were well defined, whereas smaller
cysts were present within spared tissues to varying degrees in all
R/NIR-IT treatment and control groups. Semi-quantitative
analysis of cyst size revealed no significant differences between
670 nm or 830 nm R/NIR-IT and control groups (Fig. 5D,
F= 3.9, dF= 2, P.0.05). In all groups GFAP immunoreactivity
was present around the lesion site and occasionally appeared
within ‘‘spared’’ bridges of tissue within the lesion site, whilst b-III
tubulin was present both in and around the lesions site (Fig. 5E).
In some sections b-III tubulin positive fibres were seen to traverse
across the lesion site within spared tissue, but this did not appear to
be specific for any particular group, and was therefore not
Figure 5. Analysis of functional recovery and lesion size following SCI and treatment with 670 nm or 830 nm R/NIR-IT compared to
sham treated control. Functional recovery was quantified for 28 days using BBB scores (A), Ratwalk gait analysis (B) and ladder walking (C) (n = 7 or
8/group). Semi-quantification of lesion size from toluidine blue stained sections (D), and representative images of GFAP and b-III tubulin
immunoreactivity (E) are shown at 28 days following SCI (n = 4/group), scale = 400 mm. Data are mean 6 SEM, * indicates significant differences from
pre-injury (P#0.05).
doi:10.1371/journal.pone.0104565.g005
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quantitated. Small numbers of DcX and GAP43 positive fibres
penetrated into tissue located within the cyst region, although
these tended to be located immediately at the periphery of the cyst
walls, and the number of fibres did not appear to differ between
groups (data not shown). Infiltrating macrophage numbers (ED1+)
remained high within and around the lesion area and projected
several mm beyond the lesion epicentre, with no effect of R/NIR-
IT observed (data not shown).
Discussion
R/NIR-IT has the potential to be a clinically relevant, cost-
effective and easy-to-administer treatment to reduce oxidative
stress and preserve function following traumatic injury. However,
R/NIR-IT has not been widely adopted in clinical practice for
CNS injury, in part due to the large range of treatment fluences,
irradiation time, wavelengths and devices cited in the literature
making comparisons between studies difficult. As such, a
consensus paradigm for treatment has not yet been estab-
lished[48]. Here we report the outcomes of a multi-centre
comparative study which shows that delivery of a defined number
of photons at the surface of the skin overlying a CNS injury has
differential effects on function and neuroprotection (as indicated
by Tunel staining), depending upon the wavelength used to deliver
the R/NIR-IT and the injury type.
Our study design allows the first direct comparison of efficacy of
670 nm and 830 nm R/NIR-IT, delivered by LED array, in four
models of CNS injury. We demonstrate that the most effective
wavelength for treatment depends upon the type of injury.
Specifically, 830 nm R/NIR-IT is beneficial following partial
optic nerve transection but not following light-induced retinal
degeneration. Given the greater penetrance of R/NIR-IT to the
retina than to the optic nerve, and our demonstration of efficacy of
670 nm R/NIR-IT for treatment of retinal degeneration, our data
indicate that the nature of the tissue being treated dictates the
potential efficacy of different wavelengths of irradiation. Further,
our study design allows us to demonstrate that wavelengths and
dosages of R/NIR-IT that are effective in one model of CNS
injury (e.g. partial optic nerve transection) are not necessarily
effective in another. The demonstrated penetrance of R/NIR-IT
to the site of SCI in the current study was greater than that to the
optic nerve injury site, yet there was no positive effects on function
following SCI [22]. We conclude therefore that delivery of
equivalent or greater dosages of R/NIR-IT does not guarantee
beneficial effects across different CNS injury models.
670 nm R/NIR-IT delivered by LED was generally more
effective at improving function or protecting neurons than 830 nm
R/NIR-IT, but this only applied in models involving the visual
system. The greater efficacy of 670 nm R/NIR-IT was apparent
despite a greater percentage of delivered photons of 830 nm than
670 nm R/NIR-IT penetrating through skin and muscle, leading
to a likely greater dose of 830 nm R/NIR-IT at the injury site.
Neither 670 nm nor 830 nm R/NIR-IT delivered by LED array
were effective at improving outcomes following TBI or SCI at the
dosages and time points assessed. Our data could be interpreted to
indicate that R/NIR-IT delivered by LED array is more effective
in the visual system than in other CNS injuries, but it is important
to note that the beneficial effects observed in the retinal
degeneration model may have been enhanced due to the pre-
treatment paradigm employed. Nevertheless, our study indicates
that effective R/NIR-IT treatment parameters including wave-
length and dosage do not necessarily apply in different CNS
injuries. Efficacy does not appear to be directly proportional to the
numbers of photons reaching the injury site, but may instead be a
function of the number of photons absorbed by the photoacceptor
responsible for any beneficial effects. For example, the absorbance
of cytochrome c oxidase is much greater at 670 nm than 830 nm
[66], which may explain why the 670 nm light was more effective,
despite the injury site receiving a lower fluence at this wavelength
compared to 830 nm. Furthermore, analysis of the absorption
spectra of cytochrome c oxidase within cell monolayers indicates
that the enzyme is oxidised by irradiation at 670 nm, whereas it is
reduced at 830 nm [26], perhaps also contributing to differential
efficacies.
To date, few studies have compared R/NIR-IT in CNS at two
or more wavelengths. Wong-Riley et al., 2005 assessed ATP
production by visual cortex neurons treated with 670, 728, 770,
830 or 880 nm R/NIR-IT (via LED) emitting 4 J cm22 over
80 sec in vitro, demonstrating a positive correlation with the
known absorption spectra of cytochrome c oxidase, the postulated
photoacceptor for R/NIR-IT [29]. Comparison of efficacy of 665,
730, 810 or 980 nm R/NIR-IT delivered by laser emitting 36 J
cm22 over 4 min in vivo following acute contusion TBI resulted in
significant improvements in Neurological Severity Scores in
animals treated with 665 nm and 810 nm R/NIR-IT [45].
Although these studies did not appear to standardise the dosages
for the numbers of photons delivered at different wavelengths, our
choices of wavelengths to assess in the current study were based on
those comparative assessments.
The penetrance of irradiation at a given wavelength is
determined by the optical properties of the tissue being treated.
Irradiation between 600 and 1000 nm has better penetration
because of reduced absorption at these wavelengths [48]. We
demonstrate here that while the 830 nm R/NIR-IT array
delivered an equal quantal dose to the surface of the skin
(5.3361016 photons cm22 s21), the number of photons received at
the SCI injury site was greater due to the increased penetrance of
the longer wavelength R/NIR-IT through tissue (6.061015
photons cm22 s21 for the 830 nm device compared to 3.561015
photons cm22 s21 for the 670 nm device). To our knowledge, two
published studies have quantified the penetrance of R/NIR
irradiation in animal specimens. Byrnes et al., 2005 used power
transmission and spectrophotometric analyses to show that 6%
(9 mW) of the radiant power of an 810 nm laser irradiation with a
nominal power output of 150 mW, was transferred from the dorsal
surface of the skin to the ventral side of the spinal cord [16]. We
have also previously shown that irradiation directed at the dorsal
surface of the head of the rat (R/NIR irradiance 252 W m22 550–
750 nm, WARP10, Quantum Devices), resulted in 0.1% (0.3 W
m22) reaching the ventral surface of the braincase and 0.7%
(1.75 W m22 or 0.32 J cm22) reaching the ventral surface of the
optic nerve[22]. These light levels achieved therapeutic benefits
and were significantly lower than the doses used in the superficial
wound healing studies (8 J cm22) [67] implying that relatively low
doses of light can have therapeutic benefits.
Nevertheless, delivery of doses of 28.4 J cm22 of 670 nm R/
NIR-IT or 22.6 J cm22 of 830 nm R/NIR-IT (equal quantal
doses) in the current study, equating to 1.9 J cm22 and 2.6 J cm22
respectively at the SCI injury site, did not result in improvements
following SCI. The doses we administered fall within the lower
end of the range of doses of R/NIR-IT delivered by laser and
shown to have beneficial effects in SCI (9.6–250 J cm22 [68,69]
emitted from the treatment devices). Importantly however,
previous studies demonstrating functional improvements with R/
NIR-IT following SCI utilised a substantially higher dosage of
1589 J cm22 day21 [16,21]. It remains a possibility that beneficial
effects of R/NIR-IT delivered by laser for SCI are dependent on
the coherence, narrow beam profile or some other physical aspect
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of laser light. However, a comprehensive assessment of the effects
of an increased dosage of R/NIR-IT delivered using LED arrays
would be necessary before such a conclusion could be drawn.
Alternatively, the time points at which efficacy of R/NIR-IT for
SCI were assessed may have been too early after injury to reveal
improvements, although efficacy has been demonstrated at 21
days in other SCI studies [21,69], indicating that we conducted
our assessments within an appropriate time-scale. Further, it is
possible that the handling of animals required for the 30 minute
treatments using the LED arrays, increased stress levels such that
improvements following SCI and/or TBI were masked. However,
given that efficacy was demonstrated in visual system models
where animals were handled similarly, we consider this to be
unlikely. It is perhaps more likely that the degree of inflammatory
involvement, vascular changes, cyst formation, oedema and
myelination [70–72] are likely to alter penetrance of the R/
NIR-IT [48,73] and may explain the lack of efficacy following SCI
at the current comparatively low dosage. The moderate contusion
SCI may be too severe an injury to enable detection of modest
improvements at the doses of R/NIR-IT employed in the current
study. Other spinal cord injury types such as hemisection, or
injuries targeting limited demyelination of specific tracts (e.g.
corticospinal), may prove more effective at revealing modest
improvements.
The doses of R/NIR-IT delivered by LED in the current study
also did not result in significant improvements in the tested model
of TBI. Previous assessments of efficacy of R/NIR-IT for TBI in
rodents have predominantly used lasers and have delivered doses
ranging from 1.2–268 J cm22 [74]. Improved neurobehavioural
function and reduced lesion size have been reported at four weeks
after acute, relatively severe cortical impactor injuries [45,75,76].
However, approximately equivalent dosages of R/NIR-IT, also
delivered by laser, were not effective at improving motor function
or lesion volume following a less severe cortical piston TBI,
assessed at 1 week after injury [77]. Similarly, the lack of positive
effect may be due to the relatively mild nature of the focal TBI
delivered in the current study, resulting in lack of a sufficient
window of opportunity in which to detect improvements.
Spontaneous return of function was observed by seven days after
injury in our model, rendering longer term assessments irrelevant
in this model. However, beneficial effects on function in TBI may
require a longer time scale to become apparent. Importantly, our
demonstration of lack of efficacy highlights the need to optimise
R/NIR-IT with regard to injury severity.
Our demonstration of greater efficacy of 670 nm than 830 nm
R/NIR-IT in models of injury to the visual system was
unexpected, given that more photons are likely to have been
delivered to the injury site with the 830 nm irradiation (given
calculations for the SCI injury site). It is possible that there is a
biphasic effect, with higher numbers of photons less effective than
lower numbers [41,78], such that dosage needs to be carefully
titrated for each CNS injury model to ensure the most effective
treatment protocol. Importantly however, the cellular targets in
the various CNS injury models are different. 670 nm R/NIR-IT
pre-treatment protected photoreceptors and reduced oxidative
damage to DNA in the retinal degeneration model; 830 nm R/
NIR-IT pre-treatment had no effect, with the caveat of a lower
dosage of irradiation (shorter time of exposure) delivered in this
model. It is possible that 670 nm R/NIR-IT readily penetrates to
the retina and so the dosage received is greater and thus, more
effective, than the 830 nm R/NIR-IT. In contrast, in the optic
nerve damage model, both 670 and 830 nm R/NIR-IT reduced
HNE immunoreactivity, indicative of lipid oxidation, in lipid rich
ventral optic nerve white matter vulnerable to secondary
degeneration. Furthermore, both wavelengths resulted in im-
proved visual function in this model. The types of cells that are
damaged or vulnerable in the different CNS injuries may be
critical in determining the number of photons required to
modulate disrupted cellular functions such as oxidative metabo-
lism, given differential sensitivities to oxidative stress of different
cell types [79,80]. Whether it is the neuronal somata or the lipid-
rich myelinated axons as opposed to unmyelinated axons that are
vulnerable may also influence efficacy of R/NIR-IT.
The outcomes of the study indicate that comprehensive
optimisation of the dosages, wavelengths and delivery mechanisms
(laser vs LED) of R/NIR-IT appear to be required in each model
of CNS injury, to provide an indication of effective treatment
protocols. These must then be confirmed and refined in human
clinical trials that draw upon these rationally designed pre-clinical
studies. Only then will we know whether R/NIR-IT can provide
an effective, cheap and convenient first-line treatment strategy for
CNS injury.
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